These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31606546)

  • 41. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults.
    Gamez ME; Kraus R; Hinni ML; Moore EJ; Ma DJ; Ko SJ; Rwigema JCM; McGee LA; Halyard MY; Buras MR; Foote RL; Patel SH
    Oral Oncol; 2018 Dec; 87():43-48. PubMed ID: 30527242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.
    Zumsteg ZS; Luu M; Kim S; Tighiouart M; Mita A; Scher KS; Lu DJ; Shiao SL; Mallen-St Clair J; Ho AS
    Ann Oncol; 2019 Jan; 30(1):76-84. PubMed ID: 30395159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Weiss JM; Grilley-Olson JE; Deal AM; Zevallos JP; Chera BS; Paul J; Knowles MF; Usenko D; Weissler MC; Patel S; Hayes DN; Hackman T
    Cancer; 2018 Jul; 124(14):2986-2992. PubMed ID: 29741773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
    Bucknell NW; Gyorki DE; Bressel M; Estall V; Webb A; Henderson M; Chua MS; Rischin D; Tiong A
    Australas J Dermatol; 2022 Feb; 63(1):43-52. PubMed ID: 34751431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct skin involvement of cervical lymph node metastasis from mucosal squamous cell carcinoma of the head and neck.
    Dragan AD; Nixon IJ; Orabi AA; Manganaris A; Jeannon JP; Guerrero-Urbano MT; Simo R
    J Laryngol Otol; 2013 Feb; 127(2):181-6. PubMed ID: 23217250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre.
    Estall V; Allen A; Webb A; Bressel M; McCormack C; Spillane J
    Australas J Dermatol; 2017 Nov; 58(4):e207-e215. PubMed ID: 27283245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
    Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
    Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Patel U; Pandey M; Kannan S; Samant TA; Gera P; Mittal N; Rane S; Patil A; Noronha V; Joshi A; Patil VM; Prabhash K; Mahimkar MB
    Br J Cancer; 2020 Dec; 123(12):1757-1766. PubMed ID: 32939054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
    Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
    Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck.
    Wang LS; Handorf EA; Wu H; Liu JC; Perlis CS; Galloway TJ
    Am J Clin Oncol; 2017 Aug; 40(4):429-432. PubMed ID: 25599317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.
    Wang JT; Palme CE; Morgan GJ; Gebski V; Wang AY; Veness MJ
    Head Neck; 2012 Nov; 34(11):1524-8. PubMed ID: 22109745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    Haisma MS; Plaat BEC; Bijl HP; Roodenburg JLN; Diercks GFH; Romeijn TR; Terra JB
    J Am Acad Dermatol; 2016 Oct; 75(4):722-730. PubMed ID: 27473455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
    Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Givi B; Andersen PE; Diggs BS; Wax MK; Gross ND
    Head Neck; 2011 Jul; 33(7):999-1004. PubMed ID: 21284049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.